In Case You Missed It: Presidential Debate: NACDS Injects PBM Reform Ad into D.C. Market
NACDS’ seven-figure ad campaign to advance PBM reform will reach Presidential debate viewers in the Washington, D.C. market this week.
NACDS’ seven-figure ad campaign to advance PBM reform will reach Presidential debate viewers in the Washington, D.C. market this week.
2024 NACDS Total Store Expo welcomes NACDS chain and supplier members to Boston with impressive conference schedule; opportunities to come together to collaborate, innovate and confront industry pressures.
New Pharmacy Workgroup within Sequoia’s “Interoperability Matters” program aims to foster and broaden clinical interoperability for pharmacies across the healthcare ecosystem; aligns with NACDS’ vision for the future of pharmacy and retail health
NACDS continues to urge the vital need for reforms at the federal level that will prevent “pharmaceutical benefit manipulation” across all markets – Medicare, Medicaid and commercial.
Report: “The Committee’s findings indicate that the present role of PBMs in prescription drug markets is failing and requires change”
NACDS urges “tenacity” by House Oversight and Accountability Committee in its hearing and investigation.
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S. House Committee on Oversight and Accountability hearing on PBM middlemen tactics.
Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
NACDS President and CEO Steven C. Anderson relayed recommendations in a statement for the record of the U.S. Senate Finance Committee’s hearing today on “Rural Healthcare: Supporting Lives and Improving Communities.”